benefits of health and modern pharmaceuticals. Access to generic low-priced medicines – including medicines for HIV AIDS …This paper looks at the effects of WTO/TRIPS and pharmaceuticals on women. The focus is on the poor and women. The …

, with reference to manufacturing industry in India is studied. The fact that the post-TRIPs strengthening of IPRs in India …The innovation, efficiency and productivity responses to the stronger protection of intellectual property rights post-TRIPs …

international intellectual property law for these rights will be described. India's international obligations vis-a-vis her own IPR … laws has been explained. Analysis of the public debate in India on the controversial IPRs and the status of the legislation … on these is given. This paper concludes conclude with prescriptions for public policy on IPRs and agriculture in India …

Three important aspects of the Canadian pharmaceutical industry-viz. compulsory licence, price control on patented … on important pharmaceutical products. Though the pharmaceutical industry of India and Canada share a few common points of … comparison, the most important point of divergence between Canada and India is that while the Indian pharmaceutical industry is …

The paper undertakes a detailed mapping out of the sectoral system of innovation of India's pharmaceutical industry … right, strong government research institutes and private sector enterprises which have invested in innovation. The TRIPS … discovery of drugs for neglected diseases of the developing world. Although the innovation system has the capability to develop …

WTO, the World Intellectual Property Organization (WIPO), the International Union for the Protection of New Varieties of … Plants (UPOV) and the World Health Organization (WHO), as well as the actions of NGOs active in the field of human rights …-Romande]. URL:[http://www.css-romande.ch/downloads/trips+/cssr_AdpicPlus_en.pdf]. …

RACHNA program. The programmatic framework, designed for low-prevalence contexts in India, draws on standard targeted …

The focus of this paper is India. In line with TRIPS India has introduced a product patent regime in pharmaceuticals … new drugs more suited to the needs of India and other developing countries? Can the innovation capabilities be utilized … for developing new drugs for neglected diseases? Can India contribte to lowering the cost of new drug development and make …

scenario. It also discusses the current situation regarding patenting biopharmaceuticals in India. [GIDR WP no. 168]. …